Couverture de Seliciclib
Titre du livre:

Seliciclib

Cyclin-Dependent Kinase

Part Press (28-09-2011 )

Books loader

Omni badge éligible au bon d'achat
ISBN-13:

978-613-8-59837-4

ISBN-10:
6138598377
EAN:
9786138598374
Langue du livre:
Anglais
texte du rabat:
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. R-roscovitine (Seliciclib or CYC202) is a trial drug in the family of pharmacological cyclin-dependent kinase (CDK) inhibitors that preferentially inhibit multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase or state within the cell cycle of treated cells. Seliciclib is being developed by Cyclacel. Seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation disorders. Seliciclib is a 2,6,9-substituted purine analog. Its structure in complex with CDK2 was determined in 1996. Seliciclib inhibits CDK2/E, CDK2/A, CDK7 and CDK9.
Maison d'édition:
Part Press
Site Web:
http://www.betascript-publishing.com
Edité par:
Ben Stacy Jerrik
Numéro de pages:
148
Publié le:
28-09-2011
Stock:
Disponible
Catégorie:
Chimie
Prix:
45.00 €
Mots-clés:
drug, Kinase, dependent, trial, Pharmacological, Cyclin

Books loader

Lettre d'information

Adyen::diners Adyen::jcb Adyen::discover Adyen::amex Adyen::mc Adyen::visa Adyen::cup Adyen::unionpay Adyen::paypal Paypal CryptoWallet Virement bancaire

  0 produits dans le panier
Modifier le contenu du panier
Loading frontend
LOADING